171 related articles for article (PubMed ID: 19755102)
1. CCM2 mediates death signaling by the TrkA receptor tyrosine kinase.
Harel L; Costa B; Tcherpakov M; Zapatka M; Oberthuer A; Hansford LM; Vojvodic M; Levy Z; Chen ZY; Lee FS; Avigad S; Yaniv I; Shi L; Eils R; Fischer M; Brors B; Kaplan DR; Fainzilber M
Neuron; 2009 Sep; 63(5):585-91. PubMed ID: 19755102
[TBL] [Abstract][Full Text] [Related]
2. On the death Trk.
Harel L; Costa B; Fainzilber M
Dev Neurobiol; 2010 Apr; 70(5):298-303. PubMed ID: 20186708
[TBL] [Abstract][Full Text] [Related]
3. Live or let die: CCM2 provides the link.
Gruber-Olipitz M; Segal RA
Neuron; 2009 Sep; 63(5):559-60. PubMed ID: 19755097
[TBL] [Abstract][Full Text] [Related]
4. STK25 protein mediates TrkA and CCM2 protein-dependent death in pediatric tumor cells of neural origin.
Costa B; Kean MJ; Ast V; Knight JD; Mett A; Levy Z; Ceccarelli DF; Badillo BG; Eils R; König R; Gingras AC; Fainzilber M
J Biol Chem; 2012 Aug; 287(35):29285-9. PubMed ID: 22782892
[TBL] [Abstract][Full Text] [Related]
5. Glucose regulates expression of the nerve growth factor (NGF) receptors TrkA and p75NTR in rat islets and INS-1E beta-cells.
Raile K; Klammt J; Garten A; Laue S; Blüher M; Kralisch S; Klöting N; Kiess W
Regul Pept; 2006 Jul; 135(1-2):30-8. PubMed ID: 16644033
[TBL] [Abstract][Full Text] [Related]
6. Expression of the TrkA or TrkB receptor tyrosine kinase alters the double-strand break (DSB) repair capacity of SY5Y neuroblastoma cells.
Schulte JH; Kuhfittig-Kulle S; Klein-Hitpass L; Schramm A; Biard DS; Pfeiffer P; Eggert A
DNA Repair (Amst); 2008 Oct; 7(10):1757-64. PubMed ID: 18678285
[TBL] [Abstract][Full Text] [Related]
7. Neurotrophin receptor expression in human primary retinoblastomas and retinoblastoma cell lines.
Stephan H; Zakrzewski JL; Bölöni R; Grasemann C; Lohmann DR; Eggert A
Pediatr Blood Cancer; 2008 Feb; 50(2):218-22. PubMed ID: 17973327
[TBL] [Abstract][Full Text] [Related]
8. Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas.
Schulte JH; Schramm A; Klein-Hitpass L; Klenk M; Wessels H; Hauffa BP; Eils J; Eils R; Brodeur GM; Schweigerer L; Havers W; Eggert A
Oncogene; 2005 Jan; 24(1):165-77. PubMed ID: 15637590
[TBL] [Abstract][Full Text] [Related]
9. Protein tyrosine phosphatase receptor type Z dephosphorylates TrkA receptors and attenuates NGF-dependent neurite outgrowth of PC12 cells.
Shintani T; Noda M
J Biochem; 2008 Aug; 144(2):259-66. PubMed ID: 18477627
[TBL] [Abstract][Full Text] [Related]
10. Chagas' disease parasite promotes neuron survival and differentiation through TrkA nerve growth factor receptor.
Chuenkova MV; PereiraPerrin M
J Neurochem; 2004 Oct; 91(2):385-94. PubMed ID: 15447671
[TBL] [Abstract][Full Text] [Related]
11. Induction method of tyrosine kinase A-mediated cell death in rat pheochromocytoma.
Ahn JY; Kang L; Kim HJ; Kang H; Kim SH; Kim JY; Kim SK; Wang KC; Cho BK; Lee KW; Roh JK; Kim M
Biotechnol Lett; 2005 Apr; 27(8):583-7. PubMed ID: 15973493
[TBL] [Abstract][Full Text] [Related]
12. Biological effects of TrkA and TrkB receptor signaling in neuroblastoma.
Schramm A; Schulte JH; Astrahantseff K; Apostolov O; Limpt Vv; Sieverts H; Kuhfittig-Kulle S; Pfeiffer P; Versteeg R; Eggert A
Cancer Lett; 2005 Oct; 228(1-2):143-53. PubMed ID: 15921851
[TBL] [Abstract][Full Text] [Related]
13. Caveolin-1 inhibits TrkA-induced cell death by influencing on TrkA modification associated with tyrosine-490 phosphorylation.
Jung EJ; Kim CW
Biochem Biophys Res Commun; 2010 Nov; 402(4):736-41. PubMed ID: 20977883
[TBL] [Abstract][Full Text] [Related]
14. Novel Brn3a cis-acting sequences mediate transcription of human trkA in neurons.
Valderrama X; Misra V
J Neurochem; 2008 Apr; 105(2):425-35. PubMed ID: 18086126
[TBL] [Abstract][Full Text] [Related]
15. Lysine 63 polyubiquitination of the nerve growth factor receptor TrkA directs internalization and signaling.
Geetha T; Jiang J; Wooten MW
Mol Cell; 2005 Oct; 20(2):301-12. PubMed ID: 16246731
[TBL] [Abstract][Full Text] [Related]
16. Comparison of tyrosine kinase domain properties for the neurotrophin receptors TrkA and TrkB.
Artim SC; Kiyatkin A; Lemmon MA
Biochem J; 2020 Oct; 477(20):4053-4070. PubMed ID: 33043964
[TBL] [Abstract][Full Text] [Related]
17. Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressiveness.
Cimmino F; Schulte JH; Zollo M; Koster J; Versteeg R; Iolascon A; Eggert A; Schramm A
Oncogene; 2009 May; 28(19):2015-23. PubMed ID: 19363525
[TBL] [Abstract][Full Text] [Related]
18. The Ran binding protein RanBPM interacts with TrkA receptor.
Yuan Y; Fu C; Chen H; Wang X; Deng W; Huang BR
Neurosci Lett; 2006 Oct; 407(1):26-31. PubMed ID: 16959415
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of the neurotrophin receptors p75NTR, TrkA, TrkB and TrkC in human peripheral blood mononuclear cells.
Nassenstein C; Möhring UH; Luttmann W; Virchow JC; Braun A
Exp Toxicol Pathol; 2006 Jun; 57 Suppl 2():55-63. PubMed ID: 16584874
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of insulin-like growth factor-II expression is a feature of TrkA but not TrkB activation in SH-SY5Y neuroblastoma cells.
Kim CJ; Matsuo T; Lee KH; Thiele CJ
Am J Pathol; 1999 Nov; 155(5):1661-70. PubMed ID: 10550322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
